Cargando…
Assessment of the therapeutic value of new medicines marketed in Australia
BACKGROUND: The belief that all new medicines bring a therapeutic innovation and better health outcomes is widely shared among the public, health professionals and policy makers. OBJECTIVES: To examine the therapeutic value of new medicines marketed in Australia using two classification systems. MET...
Autores principales: | Vitry, Agnes I, Shin, Ng Huah, Vitre, Pauline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987060/ https://www.ncbi.nlm.nih.gov/pubmed/24764537 http://dx.doi.org/10.1186/2052-3211-6-2 |
Ejemplares similares
-
Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
por: Vitry, Agnes I
Publicado: (2013) -
Assessment of the therapeutic value of new medicines marketed in Australia
por: Wonder, Michael J
Publicado: (2013) -
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015) -
Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015) -
“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
por: Vitry, Agnes, et al.
Publicado: (2021)